FBLN1 was observed to significantly down-regulated in RCC cell lines and patient tissues through promoter hypermethylation, and FBLN1 over expression led to decreased cell growth, enhanced tumor cell apoptosis, decreased cell motility, and angiogenesis of RCC cells in vitro and in vivo (41). The gene discussed is FBLN1; the disease is neoplasm.